Dyslipidemia in coronavirus disease 2019 pneumonia patients
Open Access
- 26 November 2020
- journal article
- Published by Peertechz Publications Private Limited in International Journal of Clinical Endocrinology and Metabolism
- Vol. 6 (1), 033-034
- https://doi.org/10.17352/ijcem.000051
Abstract
Coronavirus disease 2019 (COVID-19) pandemic has become a global threat to public health, risk factors of COVID-19 is in urgent need in this fight. We collected data and clinical records from 123 COVID-19 patients at Wuhan Union hospital, China.Keywords
This publication has 5 references indexed in Scilit:
- Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19The New England Journal of Medicine, 2020
- COVID-19: Disease, management, treatment, and social impactScience of The Total Environment, 2020
- Letter to the Editor: Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019Metabolism, 2020
- Liver injury in COVID-19: management and challengesThe Lancet Gastroenterology & Hepatology, 2020
- HIV and Antiretroviral Therapy: Lipid Abnormalities and Associated Cardiovascular Risk in HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008